Search the Newsreel

Lifeward (NASDAQ: LFWD) doubles H1 loss and warns on going concern as it adds debt

Abbott Laboratories: Revenue and Earnings Analysts Forecasts Revisions | ABT | US0028241000

Is Lifeward Ltd (LFWD) Positioned for Growth After Q2 Earnings?

Abbott India Shares Fall Over 2%

Thompson Investment Management Inc. Has $1.28 Million Stock Position in Abbott Laboratories $ABT

Toth Financial Advisory Corp Decreases Stock Holdings in Abbott Laboratories $ABT

Abbott Laboratories $ABT Shares Sold by Cox Capital Mgt LLC

West Branch Capital LLC significantly reduced its stake in Abbott Laboratories (NYSE:ABT) by 83.5% in the second quarter, selling 13,061 shares and retaining 2,576 shares worth $234,000. Despite this sell-off, institutional investors collectively own 75.18% of Abbott’s stock. Abbott reported strong Q2 earnings of …

Symbotic (SYM) On Strong Q3 And New Guidance, Is The Bull Case Already Priced In?

Serve Robotics didn’t expect Uber to sell its entire stake

Serve Robotics was surprised to learn that Uber Technologies sold its entire stake in the company, a divestment disclosed in a regulatory filing. This move coincided with a decrease in delivery volumes through Uber for Serve, the first such decline after 17 quarters of …

Serve Robotics (SERV) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 5 p.m. ET CALL PARTICIPANTS Co-founder and Chief Executive Officer - Ali KashaniChief Financial Officer - Brian Read TAKEAWAYS Revenue -- $3.2 million, up 9% sequentially and 404% year over year, driven by …

Affordable Robotic & Automation reports consolidated net loss of Rs 4.80 crore in the June 2026 quarter

Top Abbott Executive Makes Bold Move With Fresh Insider Stock Sale

An executive at Abbott Laboratories (ABT), Louis H. Morrone, recently sold 5,850 shares of company stock for $642,505. This insider transaction provides investors with additional data to consider regarding the company's current valuation. Abbott's stock performance and analyst ratings are influenced by its strong …

Ibotta director Thomas Lehrman sells $1.53m in company stock.

Ibotta director Thomas D. Lehrman sold approximately $1.53 million worth of company stock through multiple transactions on August 11 and 12, 2026. These sales, both direct and indirect, occurred at weighted average prices between $35.73 and $36.22 per share. The stock has seen a …

67,700 Shares in PROCEPT BioRobotics Corporation $PRCT Bought by Quantinno Capital Management LP

Quantinno Capital Management LP recently acquired 67,700 shares of PROCEPT BioRobotics Corporation (NASDAQ:PRCT) worth approximately $1.69 million, making it a new stakeholder in the company. Institutional investors collectively own 89.46% of PROCEPT BioRobotics, which faces mixed analyst ratings, a consensus "Hold" with a $28 …

Why PROCEPT BioRobotics (PRCT) Could Be 10% Undervalued On Reaffirmed Guidance

PROCEPT BioRobotics (PRCT) is back in focus after reaffirming its full-year guidance following Q2 2026 results, leading to a recent stock price increase despite previous longer-term declines. While a popular narrative suggests the stock is 9.4% undervalued with a fair value of $25.26 per …

Ibotta (IBTA) director Lehrman disposes of 42,407 Class A shares in August trades

Ibotta (IBTA) director Thomas D. Lehrman sold a total of 42,407 Class A Common Stock shares through six open-market transactions on August 11–12, 2026. These sales included both direct holdings and indirect sales via entities like Four Ways, LLC and LFP 2, LLC, where …

Arbe Robotics Sets September 2026 Virtual AGM, Seeks Approval for Executive Pay and Reverse Share Split

Arbe Robotics has announced its 2026 annual general meeting of shareholders for September 2, 2026, to be held virtually, where investors will vote on governance, compensation, and capital-structure items. Key agenda points include re-electing directors, approving executive compensation, and ratifying the re-appointment of KPMG …

PROCEPT BioRobotics Corporation Notice of September 22, 2026 Application Deadline for Class Action Lawsuit - Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP Before Application Deadline

Hagens Berman Sobol Shapiro LLP has filed a securities class action lawsuit against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) on behalf of investors who purchased shares between February 28, 2024, and February 25, 2026. The lawsuit alleges that PROCEPT misled investors regarding its handpiece sales …

CABOT CORP - NOTES SOLD AT 99.993% OF FACE AMOUNT

Cabot Corp. has sold notes at 99.993% of their face amount. The article is a brief news announcement from Reuters, indicating a financial transaction by the company. Further details require logging into the platform where the article is hosted.

Wellington group discloses 2.4M Cabot Corporation (CBT) shares under management

Wellington Management Group LLP and its related entities have updated their ownership report for Cabot Corporation (CBT), disclosing beneficial ownership of 2,416,471 shares, which represents 4.68% of the common stock. The filing indicates shared voting power over 1,870,169 shares and shared dispositive power over …

Lifeward Q2 2026 Earnings Preview

* Lifeward (LFWD [https://seekingalpha.com/symbol/LFWD]) is scheduled to announce Q2 earnings results on Friday, August 14th, before market open. * The consensus EPS Estimate is -$1.28 [https://seekingalpha.com/symbol/LFWD/earnings/estimates] (-312.9% Y/Y) and the consensus Revenue Estimate is $6.53M (+14.2% Y/Y). * Over the last 2 years, LFWD …

Short Interest in AMCI Acquisition Corp. (NASDAQ:AMCI) Declines By 74.1%

Arbe Robotics (ARBE) Q2 2026 Earnings Call Transcript

Symbotic (SYM) Is Down 11.5% After Swing to Profit and Higher Revenue Guidance - What's Changed

Symbotic Inc. reported a swing to profit with US$11.67 million in net income and US$720.84 million in revenue for Q3 2026, alongside higher Q4 revenue guidance of US$760 million to US$780 million. Despite these positive financial results and improved operational efficiency, the stock dropped …

Earnings To Watch: Lifeward Ltd (LFWD) Q2 2026 -- GF Value Sees 185% Upside

Abbott Laboratories (NYSE:ABT) Raised to Outperform at Wolfe Research

Wolfe Research upgraded Abbott Laboratories (NYSE:ABT) to "outperform" from "peer perform," setting a $130 price target, which suggests a 17.2% upside. This upgrade comes after Abbott's recent quarterly results surpassed expectations, with EPS of $1.31 and revenue of $12.59 billion, an increase of 13% …

PRCT DEADLINE: ROSEN, A LEADING LAW FIRM Encourages PROCEPT

The Rosen Law Firm is encouraging investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) who suffered losses exceeding $100K to secure counsel before the September 22, 2026, lead plaintiff deadline. The firm reminds purchasers of PRCT common stock between February 28, 2024, and February 25, …

What's Backing Abbott's Established Pharmaceuticals Division Growth

Abbott Laboratories' ABT Established Pharmaceuticals Division ("EPD") continues to be a solid growth contributor, supported by its broad portfolio of branded generic medicines and strong commercial presence across emerging markets. In the second quarter of 2026, EPD sales increased 8.4% on a reported basis …

Affordable Robotic & Automation Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

DUKE Robotics Corp. 2Q 2026: Revenue $149K, EPS $(0.26) — 10-Q Summary

DUKE Robotics Corp. reported its second-quarter 2026 financial results, showing revenue of $149K, a net loss of $726K, and a diluted loss per share of $(0.26). This represents a slight increase in revenue but a worsened net loss and EPS compared to the year-ago …

Form 8K DUKE Robotics Corp. For: 13 August

This article reports on the filing of a Form 8K by DUKE Robotics Corp. on August 13th. The brief notice from Investing.com indicates that this financial document was released by the company, which trades under the symbol DUKR.

Wolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffle

Investing.com -- Wolfe Research made two rating changes across large-cap medical devices, downgrading Stryker while upgrading Abbott Laboratories on Thursday. Analyst Mike Polark cut Stryker to Peer Perform, citing a demanding second-half setup following the company's March cyber disruption. He said the June quarter …

Duke Robotics Corp. (OTC: DUKR) details Q2 2026 cash boost and losses

Duke Robotics (DUKR) widens Q2 2026 loss but raises $9.2M and uplists

DUKE Robotics Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Duke Robotics Expands Grid Drone Work, Completes ~$9.2M Offering